Description
Product Overview:
CJC-1295 is a modified version of GHRH (1-29) with Drug Affinity Complex (DAC) technology, which extends its biological activity. This peptide stimulates growth hormone secretion and has been the subject of numerous research studies exploring its effects on endocrine pathways.
Key Features:
- High purity research-grade peptide
- Modified GHRH analog with extended half-life
- 30 amino acid synthetic peptide
- Enhanced stability with DAC technology
- Lyophilized powder formulation
- Third-party tested for purity and authenticity
Research Applications:
CJC-1295 has been utilized in various laboratory studies investigating growth hormone regulation, metabolic processes, and related physiological mechanisms. This compound is supplied exclusively for in vitro research and laboratory investigations.
Storage & Handling:
Store lyophilized peptide at -20°C in a dry, dark environment. After reconstitution with bacteriostatic water, store at 2-8°C and use within the recommended timeframe. Avoid exposure to light and repeated freeze-thaw cycles to maintain peptide integrity.
FOR RESEARCH USE ONLY: This product is intended strictly for laboratory research and in vitro studies. Not for human consumption, clinical use, diagnostic purposes, or therapeutic applications. Not intended to diagnose, treat, cure, or prevent any disease. Must be handled by qualified researchers in appropriate laboratory settings.






Reviews
There are no reviews yet.